Dữ liệu Xếp hạng Học thuật WoS SCIE & CAS
Bảng Xếp hạng Tạp chí Khoa học Toàn cầu
Khám phá thứ bậc học thuật, đối chiếu chỉ số Clarivate Impact Factor, phân hạng Web of Science Q1–Q4 và phân vùng CAS.
Hiển thị 51–75 của 127 tạp chí khoa học quốc tế (Pharmacy)
| Hạng | Tên Tạp chí & Mã ISSN | Impact Factor | H-Index | Phân hạng WoS | Scopus SJR | Phân vùng CAS | Tự trích dẫn | Số bài/năm | Nhà xuất bản |
|---|---|---|---|---|---|---|---|---|---|
| #51 | ChemMedChem ISSN: 1860-7179 / 1860-7187 | 3.5 | 130 | Q2 | 0.67Q1 | CAS Tier 3 | 2.8% | 304 | John Wiley and Sons Ltd |
| #52 | Current Drug Targets ISSN: 1389-4501 / 1873-5592Top Tier | 3.5 | 129 | Q2 | 0.726Q2 | CAS Tier 4 | 0% | 134 | Bentham Science Publishers B.V. |
| #53 | European Journal of Clinical Pharmacology ISSN: 0031-6970 / 1432-1041 | 3.5 | 128 | Q2 | 0.886Q2 | CAS Tier 3 | 4.2% | 151 | Springer Berlin Heidelberg |
| #54 | AAPS Journal ISSN: 1550-7416 | 3.4 | 141 | Q2 | 0.81Q1 | CAS Tier 3 | 4% | 114 | Springer International Publishing |
| #55 | Expert Opinion on Pharmacotherapy ISSN: 1465-6566 / 1744-7666Top Tier | 3.4 | 104 | Q2 | 0.765Q2 | CAS Tier 3 | 4% | 166 | Taylor and Francis Ltd. |
| #56 | Investigational New Drugs ISSN: 0167-6997 / 1573-0646 | 3.4 | 104 | Q2 | 0.816Q2 | CAS Tier 3 | 3.3% | 156 | Springer US |
| #57 | Journal of Managed Care & Specialty Pharmacy ISSN: 2376-0540 / 2376-1032 | 3.3 | 82 | Q2 | 1.212Q1 | CAS Tier 3 | 8.7% | 162 | Academy of Managed Care Pharmacy (AMCP) |
| #58 | Journal of Pharmacokinetics and Pharmacodynamics ISSN: 1567-567X / 1573-8744 | 3.3 | 77 | Q2 | 0.85Q2 | CAS Tier 3 | 13.6% | 61 | Springer US |
| #59 | Current Pharmaceutical Design ISSN: 1381-6128 / 1873-4286Top Tier | 3.2 | 197 | Q2 | 0.632Q2 | CAS Tier 4 | 3.8% | 397 | Bentham Science Publishers B.V. |
| #60 | British Journal of Clinical Pharmacology ISSN: 0306-5251 / 1365-2125 | 3 | 183 | Q2 | 1Q1 | CAS Tier 3 | 3.2% | 400 | Wiley-Blackwell Publishing Ltd |
| #61 | Current Therapeutic Research-Clinical and Experimental ISSN: 0011-393X / 1879-0313 | 3 | 50 | Q3 | 0.609Q2 | CAS Tier 4 | 0% | 30 | Elsevier Inc. |
| #62 | Expert Opinion on Drug Safety ISSN: 1474-0338 / 1744-764X | 3 | 101 | Q2 | 0.86Q2 | CAS Tier 3 | 3.3% | 160 | Taylor and Francis Ltd. |
| #63 | Molecular Pharmacology ISSN: 0026-895X / 1521-0111 | 3 | 218 | Q2 | 1.15Q1 | CAS Tier 4 | 3.1% | 80 | American Society for Pharmacology and Experimental Therapeutics |
| #64 | Fitoterapia ISSN: 0367-326X / 1873-6971 | 2.9 | 134 | Q3 | 0.511Q2 | CAS Tier 4 | 8% | 217 | Elsevier |
| #65 | Pharmaceutical Development and Technology ISSN: 1083-7450 / 1097-9867 | 2.9 | 79 | Q2 | 0.471Q2 | CAS Tier 4 | 3.8% | 83 | Informa Healthcare |
| #66 | Daru-Journal of Faculty of Pharmacy ISSN: 1560-8115 / 2008-2231 | 2.8 | 68 | Q3 | 0.519Q3 | CAS Tier 4 | 0% | 47 | Springer International Publishing |
| #67 | Journal of Pharmacological Sciences ISSN: 1347-8613 / 1347-8648 | 2.8 | 106 | Q3 | 0.891Q2 | CAS Tier 3 | 3.3% | 140 | Japanese Pharmacological Society |
| #68 | Pharmacogenomics Journal ISSN: 1470-269X / 1473-1150 | 2.8 | 101 | Q2 | 0.76Q2 | CAS Tier 3 | 0% | 56 | Springer Nature |
| #69 | Pharmacology ISSN: 0031-7012 / 1423-0313 | 2.8 | 73 | Q3 | 0.81Q2 | CAS Tier 4 | 3.4% | 78 | S. Karger AG |
| #70 | Revista Espanola De Quimioterapia ISSN: 0214-3429Diamond OA | 2.8 | 37 | Q3 | 0.611Q2 Diamond OA | CAS Tier 4 | 10.5% | 93 | Sociedad Espanola de Quiminoterapia |
| #71 | Fundamental & Clinical Pharmacology ISSN: 0767-3981 / 1472-8206 | 2.7 | 92 | Q3 | 0.671Q2 | CAS Tier 3 | 14.3% | 89 | Wiley-Blackwell Publishing Ltd |
| #72 | Drug Development and Industrial Pharmacy ISSN: 0363-9045 / 1520-5762 | 2.6 | 111 | Q3 | 0.402Q2 | CAS Tier 4 | 4.2% | 118 | Informa Healthcare |
| #73 | Journal of Natural Medicines ISSN: 1340-3443 / 1861-0293 | 2.6 | 65 | Q3 | 0.482Q2 | CAS Tier 4 | 12% | 110 | Springer Singapore |
| #74 | Journal of Pharmaceutical Policy and Practice ISSN: 2052-3211 | 2.6 | 40 | Q2 | 0.74Q1 | CAS Tier 3 | 9.1% | 85 | Springer Nature |
| #75 | Pharmacoepidemiology and Drug Safety ISSN: 1053-8569 / 1099-1557 | 2.6 | 117 | Q3 | 1.041Q1 | CAS Tier 3 | 4.2% | 166 | John Wiley and Sons Ltd |